McKinney Capital Management LLC Purchases New Position in Cigna Group $CI

McKinney Capital Management LLC purchased a new position in Cigna Group (NYSE:CI – Free Report) during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 5,051 shares of the health services provider’s stock, valued at approximately $1,373,000.

A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the stock. Osbon Capital Management LLC acquired a new stake in Cigna Group in the second quarter worth $26,000. Putney Financial Group LLC acquired a new position in shares of Cigna Group during the third quarter valued at $27,000. Johnson Financial Group Inc. acquired a new position in shares of Cigna Group during the second quarter valued at $29,000. Fiduciary Financial Advisors acquired a new position in shares of Cigna Group during the second quarter valued at $29,000. Finally, ANTIPODES PARTNERS Ltd bought a new position in shares of Cigna Group during the second quarter worth about $34,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Insider Buying and Selling

In related news, insider Nicole S. Jones sold 2,677 shares of the firm’s stock in a transaction that occurred on Tuesday, August 18th. The shares were sold at an average price of $279.61, for a total transaction of $748,515.97. Following the transaction, the insider owned 25,880 shares in the company, valued at $7,236,306.80. This trade represents a 9.37% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Everett Neville sold 617 shares of the business’s stock in a transaction that occurred on Thursday, September 3rd. The stock was sold at an average price of $284.05, for a total value of $175,258.85. Following the sale, the insider directly owned 5,053 shares in the company, valued at approximately $1,435,304.65. The trade was a 10.88% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

CI has been the topic of a number of analyst reports. Sanford C. Bernstein increased their price objective on shares of Cigna Group from $387.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday. Guggenheim cut their price objective on shares of Cigna Group from $361.00 to $347.00 and set a “buy” rating on the stock in a research report on Friday, November 6th. Evercore assumed coverage on shares of Cigna Group in a research note on Wednesday, September 9th. They set an “in-line” rating and a $290.00 target price for the company. Royal Bank Of Canada restated an “outperform” rating and issued a $337.00 target price on shares of Cigna Group in a research report on Thursday, October 1st. Finally, Jefferies Financial Group raised their price target on shares of Cigna Group from $288.00 to $304.00 and gave the company a “hold” rating in a research note on Thursday. Fourteen investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Cigna Group presently has an average rating of “Moderate Buy” and a consensus price target of $336.90.

Get Our Latest Analysis on CI

Key Cigna Group News

Here’s some of the latest news about CI:

Cigna Group Stock Performance

Shares of CI traded up $0.52 during trading hours on Friday, reaching $296.79. 1,442,187 shares of the company’s stock traded hands, compared to its average volume of 1,681,560. The firm has a market capitalization of $78.21 billion, a price-to-earnings ratio of 13.10, a P/E/G ratio of 1.11 and a beta of 0.25. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.74. Cigna Group has a twelve month low of $257.85 and a twelve month high of $318.05. The business’s fifty day simple moving average is $287.53 and its two-hundred day simple moving average is $282.70.

Cigna Group (NYSE:CI – Get Free Report) last issued its quarterly earnings data on Thursday, November 5th. The health services provider reported $7.98 earnings per share for the quarter, beating analysts’ consensus estimates of $7.52 by $0.46. The business had revenue of $73.79 billion for the quarter, compared to analysts’ expectations of $72.64 billion. Cigna Group had a net margin of 2.09% and a return on equity of 19.57%. The company’s revenue was up 5.6% on a year-over-year basis. During the same period in the previous year, the business earned $7.83 earnings per share. Analysts predict that Cigna Group will post 30.71 earnings per share for the current year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, December 17th. Shareholders of record on Thursday, December 3rd will be given a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Thursday, December 3rd. Cigna Group’s payout ratio is 27.54%.

Cigna Group Profile

(Free Report)

The Cigna Group is a global health services company that provides health insurance and related services through its Cigna Healthcare and Evernorth Health Services businesses. Cigna Healthcare offers medical, dental, behavioral health and other coverage and services to employers, individuals and government-program members. Evernorth provides pharmacy benefit management, specialty pharmacy, care delivery and other health services. Its offerings include prescription drug benefits and services for people with complex or chronic conditions.

Featured Stories

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.